DIGICANN VENTURES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | 0.00% |
|
-25.00% | +50.00% |
| Sales 2021 | 0.93 1.27 | Sales 2022 | 0.67 0.92 | Capitalization | 1.08M 1.47M |
|---|---|---|---|---|---|
| Net income 2021 | -5M -6.83M | Net income 2022 | -41M -56.04M | EV / Sales 2021 | 30,815,216 x |
| Net Debt 2021 | 20.84M 28.48M | Net Debt 2022 | 17.65M 24.13M | EV / Sales 2022 | 27,812,179 x |
| P/E ratio 2021 |
-1.35
x | P/E ratio 2022 |
-0.01
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.73% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | -25.00% | ||
| Current month | -62.50% | ||
| 1 month | -25.00% | ||
| 3 months | +50.00% | ||
| Current year | +50.00% |
1 week
0.02
0.02
1 month
0.020.05
Current year
0.010.05
1 year
0.010.25
3 years
0.01112.50
5 years
0.012 099.99
10 years
0.013 224.98
| Managers | Title | Age | Since |
|---|---|---|---|
Nicholas Kuzyk
CEO | Chief Executive Officer | 45 | 22-09-06 |
| Director of Finance/CFO | - | 21-04-30 | |
Elise Coppens
BRD | Director/Board Member | - | 21-03-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 21-04-30 | |
Nicholas Kuzyk
CEO | Chief Executive Officer | 45 | 22-09-06 |
Elise Coppens
BRD | Director/Board Member | - | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.015 | 0.00% | 29,000 |
| 24-04-25 | 0.015 | -25.00% | 2,400 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 01:06 pm EDT
More quotes
Digicann Ventures Inc., formerly Agra Ventures Ltd., is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.
Calendar
2024-04-28
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 210K | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -42.17% | 119M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- DCNN Stock
